Vimarsana
Biggest News Aggregation in the World

Ernst Bayer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ernst Bayer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ernst Bayer Today - Breaking & Trending Today

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 - Vimarsana News

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

Published: April 23, 2024

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 -- ProQR Therapeutics NV. , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™...

Source: marketscreener.com
Related Topics:
Noord HollandBart FiliusPeter KelleherAjames ShannonMartin MaierSarah KielyGerard PlatenburgTheresa HeggieDinko ValerioErnst BayerRobert StanislaroAlison LawtonIonis PharmaceuticalsAllen OveryCorporate DevelopmentAlnylam PharmaceuticalsExchange CommissionAnnual General MeetingBoard MemberSenior Vice President ResearchNorganic ChemistryProfessor ErnstChief Corporate Development OfficerGeneral CounselChief Executive Officer
ProQR Therapeutics N : AGM 2024 Explanatory Notes - Vimarsana News

ProQR Therapeutics N : AGM 2024 Explanatory Notes

Published: April 22, 2024

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V. Explanatory Notes to the Agenda ProQR Therapeutics N.V. | Zernikedreef 9...

Source: marketscreener.com
Related Topics:
United StatesUnited KingdomNoord HollandGerard PlatenburgAjames ShannonErnst BayerMartin MaierDinko ValerioRoyal College Of PhysiciansPisa PharmaceuticalsSupervisory Board Of The CompanyLeiden UniversityCompany Management BoardQueen University Of BelfastAlnylam PharmaceuticalsCompany The Supervisory BoardInternational PracticesCompany The Management BoardUniversity Of LeidenAllen OveryUniversity Of AmsterdamIonis PharmaceuticalsSalk InstituteResearch DevelopmentGlobal Head Of Pharma Development At Novartis